Kyle Jenne

Corporate Officer/Principal bei IONIS PHARMACEUTICALS, INC.

Vermögen: 83 220 $ am 30.04.2024

48 Jahre

Health Technology

Consumer Services

Aktive Positionen von Kyle Jenne

Unternehmen	Position	Beginn	Ende
IONIS PHARMACEUTICALS, INC.	Corporate Officer/Principal	29.02.2024	-
Elsie Biotechnologies Inc. Elsie Biotechnologies Inc. BiotechnologyHealth Technology Elsie Biotechnologies Inc. is a private company located in California that is focused on utilizing RNA therapeutics to treat diseases that were previously considered undruggable. The American company's platform enables the synthesis, deconvolution, and delivery of homogeneous oligonucleotide therapeutics. The company was founded in 2021 by Philip E. Dawson and Phil Baran, and the CEO is Kyle Jenne.	Direktor/Vorstandsmitglied	-	-
	Vorstandsvorsitzender	-	-

Unternehmen	Position	Beginn	Ende
IONIS PHARMACEUTICALS, INC.	Corporate Officer/Principal	-	-
AKCEA THERAPEUTICS, INC.	Corporate Officer/Principal	01.05.2017	-

Arizona State University

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Undergraduate Degree	1
Director/Board Member	1

Sektoral

Health Technology	4
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
IONIS PHARMACEUTICALS, INC.	Health Technology

Private Unternehmen	2
Akcea Therapeutics, Inc. Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA.	Health Technology
Elsie Biotechnologies Inc. Elsie Biotechnologies Inc. BiotechnologyHealth Technology Elsie Biotechnologies Inc. is a private company located in California that is focused on utilizing RNA therapeutics to treat diseases that were previously considered undruggable. The American company's platform enables the synthesis, deconvolution, and delivery of homogeneous oligonucleotide therapeutics. The company was founded in 2021 by Philip E. Dawson and Phil Baran, and the CEO is Kyle Jenne.	Health Technology

Private Unternehmen

Health Technology